Prevention of infection in neutropenic bone marrow transplant patients.
D000380:Agranulocytosis / Q000150:complications*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use; D001424:Bacterial Infections / Q000209:etiology; D016026:Bone Marrow Transplantation; D006328:Cardiac Catheterization / Q000009:adverse effects; D002408:Catheters, Indwelling / Q000009:adverse effects; D006086:Graft vs Host Disease / Q000517:prevention & control; D006561:Herpes Simplex / Q000209:etiology; D006801:Humans; D017053:Infection Control; D007410:Intestinal Diseases / Q000209:etiology; D009503:Neutropenia / Q000150:complications*; D010356:Patient Isolation; D011658:Pulmonary Fibrosis / Q000209:etiology; D012306:Risk; D018805:Sepsis / Q000209:etiology; D012874:Skin Diseases, Infectious / Q000209:etiology; D014916:Whole-Body Irradiation / Q000009:adverse effects
D000900:Anti-Bacterial Agents; D000935:Antifungal Agents; D000998:Antiviral Agents